Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
Journal of Medicinal Chemistry|August 1, 1990
Thermodynamics of the interaction of inhibitors with the binding site of recombinant human reninD E Epps, J Cheney, H Schostarez, et al.Analytical Biochemistry|August 15, 1989
An experimental method for the determination of enzyme-competitive inhibitor dissociation constants from displacement curves: application to human renin using fluorescence energy transfer to a synthetic dansylated inhibitor peptideD E Epps, H Schostarez, C V Argoudelis, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1994
Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlationsS Takikawa, V Dhawan, T Chaly, et al.The American Journal of Physiology|May 1, 1997
A carboxy-terminal peptide of the alpha 1-subunit of the dihydropyridine receptor inhibits Ca(2+)-release channelsK J Slavik, J P Wang, B Aghdasi, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Combined FDOPA and 3OMFD PET studies in Parkinson's diseaseV Dhawan, T Ishikawa, C Patlak, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 1, 1996
Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysisT Ishikawa, V Dhawan, T Chaly, et al.The American Journal of Physiology|January 14, 1999
Oxidation of the skeletal muscle Ca2+ release channel alters calmodulin bindingJ Z Zhang, Y Wu, B Y Williams, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Clinical significance of striatal DOPA decarboxylase activity in Parkinson's diseaseT Ishikawa, V Dhawan, T Chaly, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 11, 2015
Usefulness of interim analyses in portending study results in antipsychotic and antidepressant trialsJ Rabinowitz, N Werbeloff, F Mandel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1996
Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PETT Ishikawa, V Dhawan, K Kazumata, et al.Pageof 5